Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ketil Tvermosegaard"'
Autor:
Anne-Marie Jacobsen, Nico C. van de Merbel, Dorte K. Ditlevsen, Ketil Tvermosegaard, Frank Schalk, Wietske Lambert, Christoffer Bundgaard, Jan T. Pedersen, Nina Rosenqvist
Publikováno v:
Journal of the American Society for Mass Spectrometry. 34:441-451
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::704601712633ffcd09e93dae917f910d
https://doi.org/10.1021/jasms.2c00324
https://doi.org/10.1021/jasms.2c00324
Autor:
Gareth Wayne, Mike B Gray, Tony Reeves, Theresa J. Pell, Richard Kasprowicz, James D Porter, Kuljit Singh, Ketil Tvermosegaard, Sarah J Hopkins, Wendy C. Rowan, Naheem Yaqub
Publikováno v:
SLAS Discovery. 26:909-921
A core aspect of epithelial cell function is barrier integrity. A loss of barrier integrity is a feature of a number of respiratory diseases, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease. Restoration of barrier integ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0b9f5fd9e0ce87d2666fd62ed1c820
https://doi.org/10.1177/24725552211013077
https://doi.org/10.1177/24725552211013077
Single-Step, High-Efficiency CRISPR-Cas9 Genome Editing in Primary Human Disease-Derived Fibroblasts
Autor:
Klio Maratou, Radu Rapiteanu, Eleni Patili, Matteo Martufi, Tobias Schmidt, Robert B. Good, Maria New, Carmel B. Nanthakumar, Andy Blanchard, Joanna Betts, Ketil Tvermosegaard
Publikováno v:
The CRISPR Journal
Genome editing is a tool that has many applications, including the validation of potential drug targets. However, performing genome editing in low-passage primary human cells with the greatest physiological relevance is notoriously difficult. High ed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4e2a1ce9d2fe6fe8ab8cf1c4e1d9a68
https://doi.org/10.1089/crispr.2018.0047
https://doi.org/10.1089/crispr.2018.0047
Single step, high efficiency CRISPR-Cas9 genome editing in primary human disease-derived fibroblasts
Autor:
Eleni Patili, Andy Blanchard, Matteo Martufi, Joanna Betts, Robert B. Good, Ketil Tvermosegaard, Tobias Schmidt, Radu Rapiteanu, Carmel B. Nanthakumar, Klio Maratou
Genome editing is a tool that has many applications including the validation of potential drug targets. However, performing genome editing in low passage, primary human cells with the greatest physiological relevance, is notoriously difficult. High e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c821a95d961d83ce06ed2dbaf790b94f
https://doi.org/10.1101/440099
https://doi.org/10.1101/440099
